Total Knee Replacement Clinical Trial
Official title:
A Comparison of Continuous Adductor Canal Catheter Infusion vs Continuous Femoral Nerve Catheter Infusion for Total Knee Replacement Surgery
Open-labelled, randomised controlled trial. Patients will be assessed pre-operatively, at 24
and 48 hours for the primary outcome and secondary outcomes (except for Oxford Knee Score
which will be assessed pre-operatively and at 6 months post-operatively by the ortho-paedic
team).
Primary Objective: To demonstrate whether adductor canal nerve infusions result in superior
patient mobilisation within the first 48 hours following total knee replacement compared to
femoral nerve catheter infusions.
Secondary Objective: To identify whether adductor canal nerve infusions result in superior
analgesia within the first 48 hours following total knee replacement compared to femoral
nerve catheter infusions.
We are comparing a continuous adductor canal block with a low concentration continuous femoral nerve block. We currently use a low dose femoral nerve catheter based technique as part of our standard treatment strategy for total knee arthroplasty. The use of a catheter provides prolonged analgesia compared to a single shot block, and also allows a lower concentration of local anaesthetic to be employed, thus potentially reducing the incidence of motor blockade. The concentration of local anaesthetic employed in our routine practice (0.0625% L- Bupivacaine) is lower than that routinely used in many other centres, and most clinical studies have compared higher concentrations of local anaesthetic - this might be expected to produce more motor blockade. The concentration we use is higher than the minimum effective concentration for a femoral catheter infusion for knee arthroplasty. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04040985 -
Legion Primary Safety and Efficacy
|
N/A | |
Recruiting |
NCT05279092 -
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
|
Phase 2 | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Not yet recruiting |
NCT04594447 -
Physica System KR vs Physica System CR (K-20)
|
N/A | |
Completed |
NCT02413996 -
Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty
|
N/A | |
Completed |
NCT01500252 -
Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty - A Randomized Clinical Trial
|
Phase 4 | |
Completed |
NCT04081493 -
The Efficacy of Low-load Blood Flow Restricted Resistance Before TKR
|
N/A | |
Active, not recruiting |
NCT03339557 -
Comparison of Three Knee Replacements
|
N/A | |
Enrolling by invitation |
NCT04513145 -
Adductor Canal Block
|
Phase 2/Phase 3 | |
Completed |
NCT06045078 -
Aromatherapy in Total Knee Replacement
|
N/A | |
Completed |
NCT02468934 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Using the SPRINT System
|
N/A | |
Completed |
NCT02914210 -
Virtual vs. Traditional Physical Therapy Following Total Knee Replacement
|
N/A | |
Withdrawn |
NCT01523418 -
Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)
|
N/A | |
Completed |
NCT00795223 -
Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA
|
Phase 4 | |
Completed |
NCT01307202 -
Morphine Consumption in Joint Replacement Patients, With or Without Gabapentin Treatment
|
N/A | |
Completed |
NCT01515449 -
Predictors of Poor Outcomes in 1038 Sigma Knees
|
N/A | |
Completed |
NCT01522781 -
10 Year Outcome of Total Knee Replacement (TKR) Using Sigma Prosthesis
|
N/A | |
Completed |
NCT04166539 -
Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty
|
||
Completed |
NCT03454256 -
Virtual Reality Rehabilitation in Patients With Total Knee Replacement
|
N/A | |
Enrolling by invitation |
NCT06118073 -
Effect of Mindfulness on Pain After Total Knee Arthroplasty
|
N/A |